New Immunotherapy Strategies Reveal Hidden Pancreatic Cancer Cells
Northwestern scientists discovered that pancreatic tumors use a sugar-based disguise to evade the immune system by signaling 'don't attack,' but they developed a monoclonal antibody that blocks this signal, reactivating immune cells to attack the cancer in preclinical models, paving the way for potential new treatments.